Search Results - "Arusell, Robert"

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma by JENKINS, Robert B, BLAIR, Hilary, SHAW, Edward G, BUCKNER, Jan C, BALLMAN, Karla V, GIANNINI, Caterina, ARUSELL, Robert M, LAW, Mark, FLYNN, Heather, PASSE, Sandra, FELTEN, Sara, BROWN, Paul D

“…Combined deletion of chromosomes 1p and 19q is associated with improved prognosis and responsiveness to therapy in patients with anaplastic oligodendroglioma…”
Get full text

Validation of EORTC Prognostic Factors for Adults With Low-Grade Glioma: A Report Using Intergroup 86-72-51 by Daniels, Thomas B., M.D, Brown, Paul D., M.D, Felten, Sara J., B.S, Wu, Wenting, Ph.D, Buckner, Jan C., M.D, Arusell, Robert M., M.D, Curran, Walter J., M.D, Abrams, Ross A., M.D, Schiff, David, M.D, Shaw, Edward G., M.D

“…Purpose A prognostic index for survival was constructed and validated from patient data from two European Organisation for Research and Treatment of Cancer…”
Get full text

Double‐blind, randomized phase 3 trial of low‐dose 13‐cis retinoic acid in the prevention of second primaries in head and neck cancer: Long‐term follow‐up of a trial of the Eastern Cooperative Oncology Group‐ACRIN Cancer Research Group (C0590) by Bhatia, Aarti K., Lee, Ju‐Whei, Pinto, Harlan A., Jacobs, Charlotte D., Limburg, Paul J., Rubin, Philip, Arusell, Robert M., Dunphy, Eamonn P., Khandekar, Janardan D., Reiner, Seth A., Baez‐Diaz, Luis, Celano, Paul, Li, Shuli, Li, Yi, Burtness, Barbara A., Adams, George L., Pandya, Kishan J.

“…BACKGROUND 13‐Cis retinoic acid (13‐CRA) is a synthetic vitamin A derivative. High‐dose 13‐CRA in patients with squamous cell cancers of the head and neck…”
Get full text

Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177 by Brown, Paul D, Krishnan, Sunil, Sarkaria, Jann N, Wu, Wenting, Jaeckle, Kurt A, Uhm, Joon H, Geoffroy, Francois J, Arusell, Robert, Kitange, Gaspar, Jenkins, Robert B, Kugler, John W, Morton, Roscoe F, Rowland, Jr, Kendrith M, Mischel, Paul, Yong, William H, Scheithauer, Bernd W, Schiff, David, Giannini, Caterina, Buckner, Jan C

“…Epidermal growth factor receptor (EGFR) amplification in glioblastoma multiforme (GBM) is a common occurrence and is associated with treatment resistance…”
Get full text

Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study by Laack, Nadia N, Brown, Paul D, Ivnik, Robert J, Furth, Alfred F, Ballman, Karla V, Hammack, Julie E, Arusell, Robert M, Shaw, Edward G, Buckner, Jan C

“…To evaluate the effects of cranial radiotherapy (RT) on cognitive function in patients with supratentorial low-grade glioma. Twenty adult patients with…”
Get more information

Effects of Radiotherapy on Cognitive Function in Patients With Low-Grade Glioma Measured by the Folstein Mini-Mental State Examination by Brown, Paul D., Buckner, Jan C., O’Fallon, Judith R., Iturria, Nancy L., Brown, Cerise A., O’Neill, Brian P., Scheithauer, Bernd W., Dinapoli, Robert P., Arusell, Robert M., Curran, Walter J., Abrams, Ross, Shaw, Edward G.

“…To assess the neurocognitive effects of cranial radiotherapy on patients with low-grade gliomas, we analyzed cognitive performance data collected in a…”
Get full text

A prospective study of quality of life in adults with newly diagnosed high-grade gliomas : The impact of the extent of resection on quality of life and survival by BROWN, Paul D, MAURER, Matthew J, LUNSFORD, L. Dade, MCL. BLACK, Peter, BERGER, Mitchel S, KAYE, Andrew H, RUMMANS, Teresa A, POLLOCK, Bruce E, BALLMAN, Karla V, SLOAN, Jeff A, BOEVE, Bradley F, ARUSELL, Robert M, CLARK, Matthew M, BUCKNER, Jan C

“…To describe the quality of life (QOL) over time for adults with newly diagnosed high-grade gliomas and to examine the relationship between QOL and outcome data…”
Get full text

Prospective study of quality of life in adults with newly diagnosed high-grade gliomas by BROWN, Paul D, BALLMAN, Karla V, BUCKNER, Jan C, RUMMANS, Teresa A, MAURER, Matthew J, SLOAN, Jeff A, BOEVE, Bradley F, GUPTA, Lalit, TANG-WAI, David F, ARUSELL, Robert M, CLARK, Matthew M

“…To assess baseline quality of life (QOL) and its prognostic importance for adults with newly diagnosed high-grade gliomas, we analyzed QOL and outcome data…”
Get full text

Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer by Schild, Steven E, Bonner, James A, Shanahan, Thomas G, Brooks, Burke J, Marks, Randolph S, Geyer, Susan M, Hillman, Shauna L, Farr, Jr, Gist H, Tazelaar, Henry D, Krook, James E, Geoffroy, Francois J, Salim, Muhammad, Arusell, Robert M, Mailliard, James A, Schaefer, Paul L, Jett, James R

“…This Phase III study was performed to determine whether twice-daily (b.i.d.) radiotherapy (RT) resulted in better survival than once-daily (q.d.) RT for…”
Get more information

A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of life by Brown, Paul D, Decker, Paul A, Rummans, Teresa A, Clark, Matthew M, Frost, Marlene H, Ballman, Karla V, Arusell, Robert M, Buckner, Jan C

“…To examine whether a caregiver can provide reliable proxy quality of life (QOL) ratings of their adult significant other with a newly diagnosed high-grade…”
Get full text

Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma by Brown, Paul D, Buckner, Jan C, O'Fallon, Judith R, Iturria, Nancy L, O'Neill, Brian P, Brown, Cerise A, Scheithauer, Bernd W, Dinapoli, Robert P, Arusell, Robert M, Curran, Walter J, Abrams, Ross, Shaw, Edward G

“…The outcome and cognitive performance data collected in a prospective, intergroup clinical trial were analyzed to assess the prognostic importance of the…”
Get more information

Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial by Brown, Paul D, Buckner, Jan C, O'Fallon, Judith R, Iturria, Nancy L, Brown, Cerise A, O'Neill, Brian P, Scheithauer, Bernd W, Dinapoli, Robert P, Arusell, Robert M, Abrams, Ross A, Curran, Walter J, Shaw, Edward G

“…Supratentorial pilocytic astrocytomas in adults are uncommon. A prospective clinical trial was conducted to obtain clinical and outcome data in these patients…”
Get more information

Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM by Jaeckle, Kurt A., Ballman, Karla V., Giannini, Caterina, Schomberg, Paula J., Ames, Matthew M., Reid, Joel M., McGovern, Renee M., Safgren, Stephanie L., Galanis, Evanthia, Uhm, Joon H., Brown, Paul D., Hammack, Julie E., Arusell, Robert, Nikcevich, Daniel A., Morton, Roscoe F., Wender, Donald B., Buckner, Jan C.

“…Irinotecan has radiosensitizing effects and shows synergism with nitrosoureas. We performed a Phase II study of RT and irinotecan, followed by BCNU plus…”
Get full text

Double blind phase III trial of effects of low dose 13-cisretinoic acid on prevention of second primaries in stages I-II head and neck cancer: A trial of the ECOG-ACRIN Cancer Research Group (C0590) by Bhatia, Aarti K., Lee, Ju-Whei, Pinto, Harlan, Jacobs, Charlotte D., Limburg, Paul J., Arusell, Robert, Dunphy, Eamonn Patrick, Khandekar, Janardan D., Reiner, Seth, Baez-Diaz, Luis, Celano, Paul, Li, Shuli, Li, Yi, Burtness, Barbara, Pandya, Kishan J.

“…Abstract only…”
Get full text

Double-Blind, Randomized Phase III Trial of Low-Dose 13-Cisretinoic Acid in Prevention of Second Primaries in Head and Neck Cancer: Long-Term Follow-up of a Trial of the ECOG-ACRIN Cancer Research Group (C0590) by Bhatia, Aarti K., Lee, Ju-Whei, Pinto, Harlan A., Jacobs, Charlotte D., Limburg, Paul J., Rubin, Philip, Arusell, Robert M., Dunphy, Eamonn P., Khandekar, Janardan D., Reiner, Seth A., Baez-Diaz, Luis, Celano, Paul, Li, Shuli, Li, Yi, Burtness, Barbara A., Adams, George L., Pandya, Kishan J.

Get full text

Validation of EORTC Prognostic Factors for Adults with Low-Grade Glioma: a Report Utilizing Intergroup 86-72-511 by Daniels, Thomas B., Brown, Paul D., Felten, Sara J., Wu, Wenting, Buckner, Jan C., Arusell, Robert M., Curran, Walter J., Abrams, Ross A., Schiff, David, Shaw, Edward G.

Get full text

Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma by Dinapoli, R P, Brown, L D, Arusell, R M, Earle, J D, O'Fallon, J R, Buckner, J C, Scheithauer, B W, Krook, J E, Tschetter, L K, Maier, J A

“…We performed a randomized trial to compare survival distributions and toxicity of radiation therapy (RT) and PCNU with those of RT and carmustine (BCNU) in…”
Get more information